Sign for Notice Everyday    注册| 登陆| 友情链接| English|

Our Sponsors


    13th International Conference on Biosimilars and Biologics

    View: 270

    Website https://biosimilars.annualcongress.com/ | Want to Edit it Edit Freely

    Category Biosimilars Conferences, Biosimilars 2019, Euro Biosimilars, Pharmaeutical Meetings, Biosimilars Meetings, Biosimilars Conference, Biosimilars Congress, Biosimilars Events

    Deadline: February 20, 2019 | Date: March 18, 2019-March 19, 2019

    Venue/Country: Amsterdam, Netherlands, Netherlands

    Updated: 2019-02-15 15:53:29 (GMT+9)

    Call For Papers - CFP

    Best Platform for Your Research

    Dear Researcher,

    With so many challenges in Research and Industrial Market, still class of Biosimilars is experiencing the maximum growth through worldwide. Keeping these points in mind we are organizing the “13th International Conference on Biosimilars & Biologics” during March 18-19, 2019 at Amsterdam, Netherlands with the theme: European Biosimilars: Present Scenario & Future Prospects.

    For more details, PS: http://bit.ly/biosimilarsprogram

    For one day participation, register for 120 Euros only.

    We believe your work in the research field will be an excellent addition to our conference as many of our visitors will look forward to hearing and learning from your work.

    We would like to know participation status towards our conference at your earliest convenience.

    Look forward to hear from you soon.

    Note: 50% Waiver on Groups

    Regards

    Smruthi Paul

    Program Director | Biosimilars Congress 2019


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.